Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 5 Key Players companies in Hemorrhagic Fevers
by Most Patent Filings in the China in 2022

The Hemorrhagic Fevers top 5 is Discovery PatSnap’ annual ranking of the top 5 Most Patent Filings Hemorrhagic Fevers Key Players in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Viral hemorrhagic fevers (VHFs) are a group of illnesses caused by four families of viruses. These include the Ebola and Marburg, Lassa fever, and yellow fever viruses. VHFs have common features: they affect many organs, they damage the blood vessels, and they affect the body's ability to regulate itself. Some VHFs cause mild disease, but some, like Ebola or Marburg, cause severe disease and death.

VHFs are found around the world. Specific diseases are usually limited to areas where the animals that carry them live. For example, Lassa fever is limited to rural areas of West Africa where rats and mice carry the virus.

The risk for travelers is low, but you should avoid visiting areas where there are disease outbreaks. Because there are no effective treatments for some of these viral infections, there is concern about their use in bioterrorism.

Centers for Disease Control and Prevention

#
Company Name
Region
Tech Topics
Total
1
Royal (Wuxi) Bio-Pharmaceutical Co., Ltd.
Medicine,Diagnostic Reagent,Biological product
Patent: 3
2
Dong-E-E-Jiao Co., Ltd.
Herb,Medicine,Herb medicine,
...[+1]
Patent: 1
3
Ningbo Health Gene Technologies Co. Ltd.
Clinical research,Molecular diagnostics,Nucleic Acid Testing
Patent: 1
4
Weifang Kanghua Biotechnology Co. Ltd.
Patent: 1
5
Zhejiang Vacin Biomedicine Ltd
Patent: 1
Page generation time: May 17 2025